SEC filing record
Primary Source · SEC.gov

Bioliberty Ltd

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2026-10-26Last filing 2026-10-26

Raised

$336K

Investors

2

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Bioliberty Ltd is a United Kingdom entity that filed a Form D with the SEC on October 26, 2026 in the Other Technology industry group. The offering claims Rule 506(b) and covers equity. Bioliberty Ltd reported $335,906 sold from 2 investors of a $660,905 total offering as of the Form D filed October 26, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 3f Canning Exchange, 10 Canning Street, Edinburgh, X0 EH3 8EG.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002151818
Entity NameBioliberty Ltd
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeOther
Jurisdiction of OrganizationUnited Kingdom
Issuer Address3f Canning Exchange, 10 Canning Street, Edinburgh, X0 EH3 8EG
Phone(816) 753-1000
Industry / Fund TypeOther Technology
Securities TypeEquity
First Sale DateOctober 16, 2026
Filing DateOctober 26, 2026
Accession Number0002151818-26-000002
Total Offering Amount$660,905
Total Amount Sold$335,906
Amount Remaining$324,999
Total Investors2
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Proceeds to Related Persons$0
Revenue RangeDecline to Disclose
State (Issuer Address)X0
Amendment Count2 filings on record
Signed ByBarry Hextall, Company Secretary and CFO

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

2

latest Oct 26, 2026

Critical / warning

0 / 0

0 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

2

closed, raising

Latest event New filer · Oct 26, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 2 filing events with values and deltas, latest 2026-10-26, and alerts on the next one
  • 2 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Barry Hextall

Executive Officer · Edinburgh, X0

Rowan Armstrong

Director · Edinburgh, X0

Conan Bradley

Director · Edinburgh, X0

Shea Quinn

Director · Edinburgh, X0

Ross O'Hanlon

Director · Edinburgh, X0

Ramy El-Madany

Director · Edinburgh, X0

David O'Reilly

Director · Edinburgh, X0

Russell Bailey

Director · Edinburgh, X0

Dana Strauss

Director · Edinburgh, X0

Albert Nicholl

Director · Edinburgh, X0

Questions About Bioliberty Ltd

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Bioliberty Ltd?

Bioliberty Ltd is a United Kingdom entity that filed a Form D with the SEC on October 26, 2026 in the Other Technology industry group. The filing claims Rule 506(b) for an offering of equity.

Is Bioliberty Ltd legit?

AltStreet does not rate legitimacy; it reports the public record. Bioliberty Ltd filed a Form D with the SEC on October 26, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $335,906 sold to 2 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Bioliberty Ltd registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Bioliberty Ltd claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Bioliberty Ltd raised?

Bioliberty Ltd reported $335,906 sold from 2 investors of a $660,905 total offering as of the Form D filed October 26, 2026.

Who can invest in Bioliberty Ltd?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Bioliberty Ltd?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Bioliberty Ltd and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Bioliberty Ltd?

The Form D lists 10 related persons: Barry Hextall, executive officer; Rowan Armstrong, director; Conan Bradley, director; Shea Quinn, director; Ross O'Hanlon, director; Ramy El-Madany, director; David O'Reilly, director; Russell Bailey, director, and 2 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Bioliberty Ltd located?

The issuer's address on its SEC filings is 3f Canning Exchange, 10 Canning Street, Edinburgh, X0 EH3 8EG. Its phone number of record is 816-753-1000. It is organized under the laws of United Kingdom.

How long is the Bioliberty Ltd offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Bioliberty Ltd's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.